https://www.marketscreener.com/quote/stock/VAXXINITY-INC-129226100/news/Vaxxinity-Announces-UB-312-Successfully-Met-Primary-Objectives-of-Phase-1-Clinical-Trial-in-Parkinso-44179483/?utm_source=telegram&utm_medium=social&utm_campaign=share